Global Oligonucleotide Synthesis Market Report 2021: Market is Poised for Explosive Growth as Gene Technology Moves into Mainstream Healthcare, Food Production and, Even, Data Storage
August 03, 2021 06:58 ET
|
Research and Markets
Dublin, Aug. 03, 2021 (GLOBE NEWSWIRE) -- The "Oligonucleotide Synthesis Markets - Forecasts by Oligo Length, Application, and Product - With Executive and Consultant Guides and including Customized...
Global Prime Editing and CRISPR Market is Expected to Reach $23.49 Billion by 2030: Says AMR
July 13, 2021 08:54 ET
|
Allied Market Research
Portland, OR, July 13, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Prime Editing And CRISPR Market was estimated at $2.69 billion in 2020 and is...
Global $34.31 Billion Cell and Gene Therapy Markets, 2015-2020, 2025F, 2030F
July 12, 2021 04:38 ET
|
Research and Markets
Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Cell and Gene Therapy market Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change" report has been added to...
Global Cell Therapy Market Report 2021 Featuring Fibrocell Science., JCR Pharma, PHARMICELL, Osiris, MEDIPOST, Vericel, Anterogen, Kolon TissueGene, Stemedica Cell Technologies, and AlloCure
June 30, 2021 04:33 ET
|
Research and Markets
Dublin, June 30, 2021 (GLOBE NEWSWIRE) -- The "Cell Therapy Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global cell...
CRISPR and Cas Genes Markets, 2028 by Product & Service (Vector-based Cas, DNA-free Cas), Application (Biomedical, Agriculture)
June 16, 2021 06:08 ET
|
Research and Markets
Dublin, June 16, 2021 (GLOBE NEWSWIRE) -- The "CRISPR and Cas Genes Market Size, Share & Trends Analysis Report by Product & Service (Vector-based Cas, DNA-free Cas), by Application...
Arbor Continues to Build Therapeutic Focus with Key Scientific Leaders
May 27, 2021 08:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company discovering and developing the next generation of genetic medicines, announced today...
Comprehensive Analysis of 250+ Key Companies Developing 250+ Novel CAR-T Therapies: DelveInsight
April 20, 2021 20:50 ET
|
DelveInsight Business Research LLP
Los Angeles, USA, April 20, 2021 (GLOBE NEWSWIRE) -- Comprehensive Analysis of 250+ Key Companies Developing 250+ Novel CAR-T Therapies: DelveInsight More than 50% of trials investigating...
Arbor Biotechnologies Names Devyn Smith, Ph.D., as CEO
April 01, 2021 08:00 ET
|
Arbor Biotechnologies Inc
CAMBRIDGE, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early-stage life sciences company unlocking nature’s genetic diversity to enable revolutionary gene editing...
Amfora Raises $6 Million with Investment from Leaps by Bayer and Spruce Capital Partners
March 23, 2021 12:56 ET
|
Amfora Inc
SAN FRANCISCO, March 23, 2021 (GLOBE NEWSWIRE) -- Amfora, Inc., a biotechnology company that is using gene editing to increase the protein density of soybean and other crops to fuel the plant-based...
Cytovia Therapeutics Opens Boston R&D Center of Excellence and Announces cGMP Manufacturing Facility, Aiming to Start Clinical Trials for its Gene-Edited iPSC CAR-NK Cells by 2022
March 17, 2021 09:39 ET
|
Cytovia Therapeutics
R&D labs for NK cell biology, gene-editing, antibody and CAR development, and NK cell pilot manufacturing opens in Natick, MACell therapy manufacturing facility with best-in-industry clinical and...